FDA 483_RESPONSE - Wickliffe Pharmaceutical Inc - September 15, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This 483 RESPONSE record concerns Wickliffe Pharmaceutical Inc, with an inspection on September 15, 2023, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Wickliffe Pharmaceutical Inc
Inspection Date: September 15, 2023
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Jeffrey D. Meng (Associate Director)
Nicholas R. Kirkpatrick

Open in Dashboard

ID · 6e52a9b3-9a08-4849-8d99-5bbb8024469c